AGEN: Agenus, Inc. Kompaniya qiymatining sof foydaga nisbati
Agenus botensilimabning noyobligi tufayli saratonni davolash segmentida sezarli narx belgilash imkoniyatiga ega. Biznes muvaffaqiyati tartibga soluvchi organlarning tasdiqlari va strategik ittifoqlarning natijalariga bog'liq. Ushbu grafikning 11.00 ko'rsatkichi bilan ifodalangan narx tendentsiyasi yagona platformaga yuqori bog'liqlikni aks ettiradi, Agenus esa buni eski ishlanmalarga bo'lgan huquqlarni korporativ texnologik gigantlarga sotish orqali yumshatadi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_AGEN_-_Agenus_-_PE-Multiple "AGEN: Agenus Biznesning o‘zini qoplash muddati 04.07.2022 - 11.11.2026 | 👁️GURU.Markets👁️")
Agenus Inc (AGEN) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Agenus|AGEN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Agenus, Inc|AGEN - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Agenus Inc.|AGEN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Agenus|Tezkor likvidlik koeffitsiyenti agenusbio.com
- foyda va bozor multiplikatorlari tafsilotlari:
AGEN - Sof foyda|Prognoz qilingan sof foyda Agenus|AGEN - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Agenus, Inc.|AGEN - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Agenus Inc.|AGEN - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Agenus|AGEN - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi agenusbio.com|AGEN - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Agenus
Kompaniyaning har tomonlama tahlili:agenusbio.com AGEN
Agenus o'simtalarning qarshilik ko'rsatishiga qarshi kurashish uchun murakkab antitellar kombinatsiyalarini yaratish orqali global immuno-onkologiya bozorini kengaytirmoqda. Ushbu ambitsiyalar taxminiy aktiv qiymatiga bevosita ta'sir ko'rsatadi, bunda kompaniyaning joriy P/E koeffitsiyenti 11.00 darajasida qat'iy belgilangan. Ushbu koeffitsient aksiya narxini sof foyda bilan bog'lagan holda, kelajakdagi o'sish uchun bozor premiumini o'lchaydi. Ushbu metrikaning tahlili biznesning fundamental daromadlariga nisbatan haddan tashqari qimmat baholanganlik darajasini aniqlash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|TRML - P/E multiplikatori|PGEN: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti pharming.com PHAR|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Upstream Bio, Inc. UPB|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|Immunome Bio - Narx-foyda multiplikatori|Gossamer Bio, Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori kalvista.com KALV|SEPN - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pieris Pharma PVLA|SVRA: P/E multiplikatori|Rigel Corp (RIGL) - P/E multiplikatori|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|ATXS - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori ENGN|RAPT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Aerovate Therapeutics JBIO|ACRS: Narx-foyda multiplikatori|KYTX - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati TLSA|CABA: P/E multiplikatori|Ventyx Biosciences Inc. - Kompaniya qiymatining sof foydaga nisbati|THTX (Theratechnologies Inc) - P/E multiplikatori|P/E multiplikatori Avalo Therapeutics Inc|Narxning foydaga nisbati Eledon Pharmaceuticals (ELDN)|CLYM (climbbio.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Zura Bio ZURA|ATYR - Narx-foyda koeffitsiyenti|Adagene Corp - P/E multiplikatori|IMA - P/E multiplikatori|STTK (shattucklabs.com) - Narx-foyda koeffitsiyenti|Equillium - Kompaniya qiymatining sof foydaga nisbati|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|Immunic Inc (IMUX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|Narx-foyda koeffitsiyenti inflarx.de IFRX|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|ACET - Narx-foyda koeffitsiyenti|CELU: Narx-foyda koeffitsiyenti|INMB - P/E multiplikatori|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Narx-foyda multiplikatori KZR|SABS (SAB Biotherapeutics) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati akaritx.com AKTX|P/E multiplikatori ENLV|P/E multiplikatori q32bio.com (QTTB)|P/E multiplikatori GOVX (GeoVax Labs Inc)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Edesa Biotech Corp|iBio, Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Carisma Therapeutics|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda multiplikatori BOLT|Narx-foyda koeffitsiyenti HCWB|P/E multiplikatori Aptevo|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|Biznesning o‘zini qoplash muddati aditxt.com|P/E multiplikatori GRI (GRI Bio)|P/E multiplikatori XORTX Therapeutics Inc XRTX|ReShape Lifesciences - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Revelation Biosciences Corp (REVB)|INDP: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati scinai.com (SCNI)|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda multiplikatori AFMD (Affimed Therapeutics)|Narxning foydaga nisbati Allakos Inc. (ALLK)|HOOK: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori IGMS (IGM Biosciences)|Kompaniya qiymatining sof foydaga nisbati ITOS|Ocean Biomedical - P/E multiplikatori|TCBP - P/E multiplikatori|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
